Direct Measurement of Disability
October 2009
by Philip D. Harvey, PhD
Dr. Harvey is Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.
Psychiatry (Edgemont). 2009;6(10):43–46
This is protected content.
Popularity: unranked [?]
Related posts
- Polypharmacy of Schizophrenia
- COGNITION AND SCHIZOPHRENIA: Is There a Role for Cognitive Assessments in Diagnosis and Treatment?
- Risperidone Long-Acting Injections: Successful Alternative Deltoid Muscle Injections for Refractory Schizophrenia
- Real-world Data on Atypical Antipsychotic Medication Side Effects
- The Genetics of Cognitive Impairment in Schizophrenia
- Katatonia: A New Conceptual Understanding of Catatonia and a New Rating Scale
- Role of Cholinergic System and Calcium Synchronization in Schizophrenia
- The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief Training
- Prevention of Schizophrenia Relapse with Extended Release Quetiapine Fumarate Dosed Once Daily: A Randomized, Placebo-Controlled Trial in Clinically Stable Patients
Posted in Update on Cognition | No Comments »
